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Abstract
Background: The complex yet flexible cellular response to pathogens is orchestrated by the
interaction of multiple signalling and metabolic pathways. The molecular regulation of this response
has been studied in great detail but comprehensive and unambiguous diagrams describing these
events are generally unavailable. Four key signalling cascades triggered early-on in the innate
immune response are the toll-like receptor, interferon, NF-?B and apoptotic pathways, which co-
operate to defend cells against a given pathogen. However, these pathways are commonly viewed
as separate entities rather than an integrated network of molecular interactions.
Results: Here we describe the construction of a logically represented pathway diagram which
attempts to integrate these four pathways central to innate immunity using a modified version of
the Edinburgh Pathway Notation. The pathway map is available in a number of electronic formats
and editing is supported by yEd graph editor software.
Conclusion: The map presents a powerful visual aid for interpreting the available pathway
interaction knowledge and underscores the valuable contribution well constructed pathway
diagrams make to communicating large amounts of molecular interaction data. Furthermore, we
discuss issues with the limitations and scalability of pathways presented in this fashion, explore
options for automated layout of large pathway networks and demonstrate how such maps can aid
the interpretation of functional studies.
Background
The innate immune response is executed at the molecular
level by a complex series of interwoven signalling path-
ways. In this context, pathways may be defined as a net-
work of directional interactions between the components
of a cell which orchestrate an appropriate shift in cellular
activity in response to a specific biological input or event.
Whilst our ability to perform quantitative and qualitative
measurements on the cellular components has increased
massively in recent years, as has our knowledge on how
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these observations into graphical and computationally
tractable models. However without such models we can
not hope to truly understand biology at a systems level.
Traditionally, representations of molecular pathways have
been produced ad hoc and frequently included in reviews
and original papers. Whilst they are clearly useful aids to
understanding cellular events, even at their best, they are
not sufficient by themselves, relying on extensive textual
descriptions to explain what is shown pictorially. Recent
years have seen considerable growth in the availability of
public and commercial databases offering searchable
access to pathways and interaction data derived from a
combination of manual and automated (text mining)
extraction of primary literature, reviews and large-scale
molecular interaction studies. Using these tools it is pos-
sible to view a range of canonical pathway views or gener-
ate networks of interactions based on a given query.
However, all of these efforts are let down by one or a
number of key factors. The notation used in diagrams to
depict one molecule's interaction with another is varied,
often ambiguous and therefore limited in its ability to
depict the exact nature of the relationship between com-
ponents of a pathway. There is often a lack of direct access
to the experimental evidence relating to the interactions
depicted or to the dataset as a whole. Similarly, labelling
of the pathway components often uses non-standard
nomenclature or mixes protein names from one species
with that of another, such that again the reader is left
uncertain as to what exactly is being shown. Finally, path-
way diagrams usually focus only on a small part of a bio-
logical system and one which often reflects the curator's
bias, such that the 'same' pathway described by different
individuals may share little in common. Whatever the
source of these pathways and networks they generally suf-
fer from graphically poor representation with ambiguity
around the precise identity of what is being shown and
the exact nature of their interaction. In order to address
these issues the groups of Kohn and Kitano began to
devise new approaches to pathway notation using many
ideas adopted from the electronics industry [1-3]. In par-
ticular the MIM (molecular interaction map) notation [3]
a form of entity-relationship representation and the proc-
ess description notation (PDN) [1], respectively. Since
then there has been an increasing interest in the systems
biology community to develop a consensus view on a
standard approach for representing biological pathways
[4]. Whilst this process is now well advanced there is cur-
rently no internationally agreed standard graphical nota-
tion system for building pathway diagrams and a paucity
of worked examples of this type of notation in use. Exam-
ples of pathways that have been published using these
notation systems include a molecular interaction map of
macrophage signalling [5] and Toll-Like-Receptor signal-
ling [6] which have been depicted using the PDN scheme
and cell cycle control and DNA repair presented in the
MIM notation [2].
Over the last four years we have been developing a nota-
tion scheme for the depiction of biological pathways that
borrows many of the ideas of existing notation systems
but attempts to address some of their short comings. The
Edinburgh Pathway Notation [26] uses a logical state-
transition representation to describe biological pathways,
similar to PDN. The work described here follows on from
this initial publication and reports a modified version of
the EPN scheme which is aligned with the developing
international SBGN standard but has a number of impor-
tant differences with the scheme as currently proposed.
Crucially, the notation provides a logical context for inter-
actions between components in the pathway, it can dis-
play the temporal order of reactions and can be mapped
to the machine-readable SBML (systems biology markup
language) [7]. Of primary importance to this notation
scheme and indeed the SBGN is the desire to develop
pathway maps that are 'readable' by a biologist. Since the
pathway maps are primarily produced as a tool for com-
munication it is critical that they are easily understanda-
ble and the notation can be applied and read by biologists
with minimal training. Other objectives (of the SBGN) are
that the notation should be computable, compact, show
sub-cellular localization and be tolerable of incomplete
knowledge. Whilst all of these objectives are valid, fulfill-
ing them in practice is far from trivial and there are few
worked examples of large pathway diagrams depicted in
standard notations, available in the public domain.
The innate immune response is orchestrated by series of
signalling pathways that have evolved to elicit an appro-
priate defensive response to attack by pathogenic organ-
isms. Pathogen sensing involves pattern recognition
receptors such as the toll-like receptors (TLR's) which in
mammalian cells constitutes a family of up to 11 [8] trans-
membrane receptors each responsible for distinguishing
particular pathogen-associated molecular patterns
(PAMPs). Detection of pathogen molecules by these
receptors results in the recruitment of various adaptor pro-
teins and the activation of downstream signal transduc-
tion cascades [9,10]. Activation of de novo gene expression
follows, which ultimately acts to recruit new proteins and
augment the response to infection. Interferons (IFNs) are
central to this response, as are (amongst others) interferon
regulatory factors (IRFs), JAK/STAT signalling proteins
and the nuclear factor-kappa B (NF-?B) family of proteins
[11]. The IRF family of transcription factors bind specific
DNA sequences, as do the STAT proteins, present on the
promoter of target genes [12,13]. NF-?B signalling can reg-
ulate transcription through a combination of NF-?B pro-
tein homo- and heterodimers [14-17]. These pathways arePage 2 of 15
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way, thereby providing the potential for cells to undergo
a programmed cell death [18], the ultimate cellular sacri-
fice in defence of the organism.
The TLR, IFN, NF-?B and apoptosis pathways are of central
importance in defining the macrophages response to
pathogens and do so in a highly inter-dependant manner
[11]. Extensive literature describing the pathways and
their interconnectivity, like so many others in biology, is
available but only from multiple and disparate sources. In
our effort to understand these events as a basis for inter-
preting analyses of host-pathogen interactions and the
inflammatory response in the macrophage, we have
endeavoured to construct an integrated and logic-based
pathway diagram of signalling cascades fundamental to
macrophage activation using a current version of the EPN
scheme. We present the results of these labours as an
example of our on going work in this area and hope that
this map will be used to supplement and contrast with the
efforts of others [6] in this area.
Methods
Collection of Molecular Interaction Data and Biological 
Representation of Pathways
In an effort to describe and consolidate knowledge of
pathways central to macrophage activation we have con-
structed a pathway diagram based on published literature.
Ideally, two published papers citing protein-protein or
protein-gene interactions were required for the inclusion
of a given interaction on to the pathway diagram. In some
circumstances we accepted one piece of published evi-
dence if the paper described extensive experimental verifi-
cation of the interaction. This was deemed necessary as
two publications per interaction can limit inclusion of
potentially interesting interactions included in other
pathway resources (KEGG, Reactome etc) and newly dis-
covered interactions. It is also important to note that the
primary task of this exercise was to develop a 'consensus'
of knowledge and information about a given pathway.
A list of interactions to be mapped was compiled [see
Additional file 1], including details about the nature of
the interaction and source of the information. A pathway
map was then drawn using the principles laid down by the
EPN scheme. These include the concept that the molecu-
lar components of a pathway be they proteins, protein
complexes and genes (or in principle any other cellular
component that plays a part in a pathway) are represented
as simple shapes containing a unique and unambiguous
identifying label. Attempts to depict pictorially the func-
tional activity or functional domains of components have
been avoided as this adds to the visual complexity of the
diagram and can be misleading. For consistency compo-
nents (nodes) have been named by their official human
genome nomenclature (HGNC) symbol, although in cer-
tain instances we have felt it necessary due to the wide-
spread use of other naming conventions to supplement
this with additional annotation. For example we have
used the name tBID to differentiate the truncated (active)
form of the protein from its precursor (BID) and similarly
in order to distinguish the native (inactive) form of cas-
pases we used the suffix Pro e.g. ProCASP3 from the active
cleaved form (CASP3). We have also included additional
naming conventions to differentiate between protein
forms e.g. in the NF-?B pathway (p50, p52 etc) or
included common aliases where they are prevalent in the
literature, these names being placed in brackets after the
official name. Whilst the use of such ad hoc naming con-
ventions is in theory undesirable, they are still in common
use and alternative ways to differentiate between protein
forms is not supported under the HGNC and standard
naming conventions for describing proteins in their vari-
ous modified forms (truncated, cleaved, activated by
cleavage etc) does not yet exist. Where pathway compo-
nents are protein complexes, the name of the complex is
given as a concatenation of the names of its constituent
parts, although this has in some cases been supplemented
by the inclusion of common names such as 'apoptosome'
to denote the complex between CASP9, CYCS and APAF1.
Components are depicted at the site of their activity and
are shown only once in any given cellular compartment
unless different activation states of the components are
known due to phosphorylation, ubquitinisation, cleavage
etc., when these molecular states may be shown as con-
nected but individual entities. The state of a component
may be shown as a supplement to the components name
e.g. active [A], inactive [I], phosphorylated [P]. Interac-
tions (edges) between components or transitions between
one cellular compartment and another, are shown as
arrows which either contact interacting partners via
Boolean logic operators (&, OR, NOT) and/or transition/
annotation nodes that provide information as to the
nature of the interaction or transition from one state to
another. Attempts to depict molecular details of interac-
tions and state transitions such as the exact site of a pro-
tein's phosphorylation, have generally been avoided.
Whilst important, if depicted on a map of this size the
information quickly clutters up the diagram rendering it
inaccessible to the casual reader. However, in cases where
such details are necessary to differentiate one component
form from another they should be added. Finally, layout
of the elements and interactions that make up the path-
way should be such that it is relatively easy to follow the
direction and nature of flow of information from the ini-
tial trigger to the eventual outcome. In an effort to achieve
this, where possible interacting map components are
drawn close together keeping edge lengths short and easy
to follow, crossover of edges is kept to a minimum and
every effort is taken to keep connecting edges separate,Page 3 of 15
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from one point to another.
The pathway map was drawn using the freely available
program yEd graph editor (yFiles software, Tubingen, Ger-
many). yEd is a general purpose graphical tool designed
for the depiction of networks. Although not specifically
designed for biological pathway depiction it has been
used previously for this and similar purposes [19,20] and
has a range of characteristics and capabilities that make it
ideally suited for the job. Initially pathways were laid out
by hand. Areas of the canvas were defined as representing
specific compartments of the cell e.g. plasma membrane,
cytoplasm, nucleus etc., and cellular components and the
interactions in which they took part were drawn in the
appropriate space. A section of the overall map describing
IFNG receptor signalling laid out according to the cellular
location of the components has been included as an
example of the notation scheme in action (Figure 1) and
a list of notation symbols used here is provided in Figure
2.
The combined map of macrophage activation pathways
described here (Figure 3) is available for download [21]
and presented in a number of image (.jpeg, .pdf) and
graphical formats (.xml, .graphml). The .graphml file [see
Additional file 2] can be opened in yEd graph editor [22]
and in this format is available for editing or expansion.
PubMed IDs supporting the interactions of the pathway
are stored on appropriate edges within the .graphml ver-
sion of the diagram. We have found the yEd program to
be relatively intuitive to use and to require minimal or no
training. Hence the pathway diagram presented here is
easily accessible, distributable and can be modified by
end users to suit their interests or knowledge-base. The
EPN can be mapped to SBML and we are in the process of
creating a SBML version of the map described here.
As the complexity of maps increases and the interactions
between components become evermore intertwined,
manual organization of these events becomes time-con-
suming and difficult. However, the pathway diagrams
have been specifically drawn as directional networks. As
such layout of the pathway maps can be aided by use of
various automated layout algorithms. The hierarchical
layout and classic-orthogonal edge routing applications
within the yEd software were the most effective in terms of
providing an easily interpretable view of directional flow
in the diagram (Figure 4a, b). However, other layout algo-
rithms such as the organic layout function (Figure 4c) can
also provide different views of the pathway. Furthermore
this pathway can be easily converted into a 3-D network
(Figure 4d) in BioLayout Express3D [23]. Whilst 3-D path-
way networks do not readily support user readability of
Manual layout of Type II interferon signalling (IFNG) taken from the integrated pathway diagram (Figure 2)Figure 1
Manual layout of Type II interferon signalling (IFNG) taken from the integrated pathway diagram (Figure 2). 
The pathway is arranged to flow from left to right. Components are coloured according to type (protein, complex or gene) 
and arranged within the sub-cellular compartments in which they are active. This pathway is initiated by IFNG binding to its 
receptor and a subsequent phosphorylation cascade involving a number of the JAK and STAT family of proteins. Several tran-
scriptionally active complexes are formed (STAT1 homodimer, ISGF3 complex, STAT1:STAT1:IRF9 complex) and the pathway 
culminates with the transcriptional activation of target genes.Page 4 of 15
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large graphs may be plotted (15,000 nodes, 2.5 million
edges) and queried. As such these tools can aid interpreta-
tion of the innate structure within the network of interac-
tions of large pathway diagrams and together provide a
solution, albeit not necessarily a perfect one, to the issue
of scalability. With these capabilities it will be possible to
scale up these diagrams to the point where they may con-
tain thousands of components, operators and transition
nodes.
Network Analysis of the Transcriptional Response of 
Mouse Bone Marrow Derived Macrophages to Interferon-
gamma Treatment
Primary mouse bone marrow derived monocytes were
prepared from male balb/c mice 10–12 weeks old. Cells
were washed, resuspended in DMEM-F12/10% FCS/L929
medium and counted before being plated in a 24-well
plate at a concentration of 5 × 105 cells/well. To differen-
tiate the cells from monocytes into primary macrophages,
cells were then incubated for 7 days in DMEM-F12 growth
media supplemented with 10% L929 cell suspension
releasing the MCP-1 macrophage stimulating factor, with
media changes on days 3 and 5. On day 7 the growth
medium was replaced with DMEM-12/10%FCS medium
containing 10 u/ml recombinant mouse interferon-
gamma (Pierce-Thermofisher Scientific, Rockford US) and
harvested 1, 2, 4 & 8 h following treatment or collected
pre-treatment (0 h). Total RNA was harvested from the
cells using an RNeasy Plus kit (Qiagen) according to man-
ufacturer's instructions. RNA was quantified and quality
controlled using a NanoDrop spectrophotometer (Nano-
Symbols of the modified Edinburgh Pathway NotationFigure 2
Symbols of the modified Edinburgh Pathway Notation. Unique shapes and identifiers are used to distinguish between 
each element of the notation allowing its interpretation even in the absence of colour. Colour maybe used for aesthetic pur-
poses and to ease identification of nodes. The notation can be broadly divided into four categories; components, boolean oper-
ators, transition nodes and annotated edges. Components consist of any interacting species from proteins, complexes, genes 
or other molecular species (pathogens, DNA, RNA). Pathway initiators are also presented in the notation. Boolean operators 
are essential for capturing the dependencies of an interaction. Transition nodes provide information as to the nature of the 
interaction (such as cleavage, translocation, phosphorylation). Edges are directional and can be coloured for visual impact. Dis-
tinctive arrow-heads are used to distinguish between the pathway inputs and outputs but are otherwise avoided. Instead in-line 
edge annotation is used to add a visual cue as to the meaning of an edge. Cellular compartmental information is provided by 
physical location and backdrop or by colouring nodes according to their sub-cellular location.Page 5 of 15
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Integrated pathway map of signalling in the macrophageFigu e 3
Integrated pathway map of signalling in the macrophage. The diagram includes the interferon signalling, NF-?B, apop-
tosis and toll-like receptor pathways, all represented as one integrated pathway due to their overlapping interactions. In gen-
eral interactions of the interferon response pathway are in the top quarter of the map, with NF-?B directly below. Apoptosis is 
presented halfway down the map and toll-like receptor signalling is in the bottom quarter. 154 different protein or gene nodes 
are included in the pathway, along with 80 different complexes and 12 other molecular species (such as pathogens, DNA, 
RNA). The pathway diagram represents 272 different interactions.
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Page 7 of 15
(page number not for citation purposes)
Automated layouts of the pathway diagramFigure 4
Automated layouts of the pathway diagram. (4a) a hierarchical-classic layout was applied to the entire pathway and the 
orientation was set to flow from left to right. Nodes are coloured according to their sub-cellular location. With this layout the 
flow of pathway information and biological logic is maintained, such that the inputs to pathway are placed at the left side of the 
diagram and these can be followed through to the outputs at the right hand side. (4b) a detailed inset of the hierarchical-classic 
layout of the integrated pathway taken from 4a. (4c) Organic-classic automated layout of the entire pathway generated in yEd 
graph editor. Although the directionality of flow in the pathway is lost, interacting partners tend to be placed in close proximity 
of each other in this layout. (4d) a 3-dimentional network of the apoptosis interactions in the pathway generated using BioLay-
out Express3D. This network can be queried for pathway information. Unique shapes are used to identify the different pathway 
notation symbols; spheres denote interacting components (proteins, genes, complexes), decahedron shapes represent boolean 
operators or transition nodes and tetrahedron shapes correspond to the in-line edge annotation (in this case activation, or 
inhibition). All notation symbols are coloured to correspond to the colour scheme applied in the 2-dimentional pathway dia-
gram (e.g. complexes are yellow, proteins are blue, and activation-annotations are green). Furthermore interacting compo-
nents are sized according to type, such that spheres representing complexes appear larger than proteins or genes. As with the 
2-dimentional diagram the colour scheme used is customisable. The 3-dimentional network retains the information captured in 
the 2-dimentional pathway and although spatial placement of nodes in relation to their sub-cellular location has been lost, this 
information can be retrieved by querying the network and/or colouring nodes according to their sub-cellular location.
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licate 150 ng samples of total RNA derived from two
separate wells per time point were labelled using the
Affymetrix whole transcript labelling protocol and hybrid-
ized for 16 h at 45°C to Affymetrix mouse exon 1.0 ST
arrays. They were then washed and scanned according to
manufacturer's recommendations.
Data (ArrayExpress Ac. No: E-MEXP-1490) was normal-
ized using the RMA package within the Affymetrix Expres-
sion Console software and annotated. Transcripts which
might be considered to be differentially expressed were
identified using either the Empirical Bayes function
within Bioconductor [24] or using the annova function
within GeneSpring (Agilent Technologies, Stockport,
Cheshire) with a 1.6 fold cut-off. In total 1,678 transcripts
were identified by one or both of these filters. The data
corresponding to this list was then loaded into the net-
work visualization tool BioLayout Express3D [23] using a
Pearson correlation cut-off of 0.9 to filter edges. The
resultant network graph (Figure 5a) of 1,491 nodes was
clustered using the graph-based clustering algorithm MCL
[25] set at an inflation value of 2.2 resulting in 26 clusters
(Figure 5a & b). Clusters composed of transcripts that
were up-regulated were then further collated into 3
groups; genes up-regulated at (1) 1–2 hours, (2) 2–4
hours and (3) 4–8 hours post-treatment and genes that
were both differently expressed and present on the inte-
grated pathway diagram were highlighted on the map.
Results and Discussion
We set out to use the EPN scheme as originally published
[26]. However, during construction of the maps described
here the notation system was found to be too limiting to
convey certain biological concepts and overly compli-
cated for others. A simplification of certain aspects of the
notation was therefore deemed necessary in order to
achieve the objectives outlined above, in particular
human readability. Modifications made to the EPN were
not intended to change the built in logic of the notation
scheme but rather merely enhance the visual characteris-
tics of the diagrams produced. One of the major modifica-
a) A network graph of differentially expressed genes following Ifng treatmentFigur  5
a) A network graph of differentially expressed genes following Ifng treatment. A Pearson correlation cut-off of 0.9 
was set to filter edges in the network and the resultant graph was clustered using the graph-based clustering algorithm MCL 
set at an inflation value of 2.2. Each node represents a transcript and nodes are coloured according to the cluster to which they 
belong. Nodes belonging to the same cluster share a common pattern of expression over the time-course following Ifng treat-
ment. b) A view of the 26 clusters defined from the network graph in 5a. The size of each sphere representing a clus-
ter corresponds to the size of its node membership. Clusters are assigned a description of the co-expression pattern they 
present over the time course and are coloured according to whether the nodes within those clusters are up-regulated 
(orange) or down-regulated (green) following the Ifng treatment.
a bPage 8 of 15
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(and the emerging SBGN standard) on multiple types of
arrow heads to infer different meaning to the interactions.
We have used only one type of arrowhead and relied far
more heavily on the use of transition nodes or annotation
nodes to infer the nature of the transition from one
molecular state to another and add information to edges.
We found this system to improve the readability of the
maps as well as provide greater flexibility in the range of
concepts that may be depicted. The pathway diagrams cre-
ated using this notation scheme function without the use
of colour and do not therefore lose their semantics if
viewed without it. Nevertheless, colour does provide a
powerful device for increasing the visual impact of the fig-
ure. Here we have generally chosen apposite or symbolic
colours to represent the appropriate interaction; for exam-
ple red for inhibition, green for activation. However, it
must be emphasized that the exact colour scheme is not
important and should be seen as customizable to suit an
individuals taste or limitations in colour recognition.
The pathway map described here (Figure 3) consists of a
total of 295 nodes of which 140 are proteins, 99 com-
plexes, 44 genes, and 12 other components (pathogens,
DNA, RNA etc). A total of 272 interactions are described
in the pathway map, of these 85 are binding events, 149
are various activation state modulations (67 activation of
gene expression, 26 phosphorylation, 7 auto-phosphor-
ylation, 1 dephosphoylation, 23 cleavage, 9 transloca-
tions and 16 activation by processes not defined). There
are 10 inhibition reactions, 4 of these are inhibition of
gene expression, 3 are inhibition of cleavage, and 1 is an
inhibition of translocation. A total of 26 translocation
events occur as well as 2 protein dissociations. 282 differ-
ent references support the interactions shown on the path-
way [see Additional file 3]. In many circumstances the
same paper may describe multiple interactions, for exam-
ple Chaudhary et al., (1997) report that both TNFRSF10A
and TNFRSF10B recruit the protein FADD during apopto-
sis signalling [27]. A detailed description of the biological
content of this pathway diagram is given in Additional file
4.
In order to check the integrity of the network each input
(e.g. cytokine or pathogen molecule), was highlighted in
turn and the logical flow of information from this input
followed through the diagram. By following the flow of
information from each pathway input, a different but
expected output was observed, be that the activation of
transcription or a process such as apoptosis (Figure 6a &
b). This suggests that although several signalling pathways
have been integrated to form this diagram the specificity
of connectivity has not been lost.
Use of Pathway Diagram in the Interpretation of 
Transcriptomics Data
In order to demonstrate the utility of this pathway dia-
gram in the interpretation of transcriptomics data we have
examined the transcriptional events following the treat-
ment of mouse bone marrow derived macrophages
(BMDM) with interferon-gamma (Ifng). Using the net-
work analysis tool BioLayout Express3D [23] we con-
structed a 3-D network of transcripts identified as being
differently expressed following Ifng stimulation (Figure
5a). 1,491 transcripts were represented within the net-
work, 1,274 of which grouped into 26 clusters with ? 5
members (Figure 5b). There are 154 unique proteins/
genes represented on the pathway map, 55 of which are
represented within these clusters and a further 3 compo-
nents were in the transcriptional network but did not fall
into a cluster [see Additional file 5]. All of the genes repre-
sented on the map were in clusters of up-regulated genes.
Clusters of transcripts representing genes activated at dif-
ferent times following treatment were then further col-
lated into 3 groups of up-regulated genes; genes activated
at (1) 1–2 hours, (2) 2–4 hours and (3) 4–8 hours post-
treatment. Genes that were activated and included in the
set of mapped genes were then highlighted on the map
and the possible downstream consequences (assuming de
novo protein synthesis and activity following an increase
in gene transcription) were highlighted (Figure 7). In this
way is has been possible for the first time to interpret these
transcriptional events in the context of the possible conse-
quences of these observations.
During the very early phase (0–2 hours) of the response to
Ifng treatment only two genes, SOC3 and IER3, corre-
sponded to pathway components shown in the diagram
(Figure 7a). SOCS3 (suppressor of cytokine signalling 3)
is an inhibitory protein of Interferon-gamma receptor
complex signalling and has also been reported elsewhere
to be expressed in macrophages following interferon treat-
ment [28]. The up-regulation of SOCS3 represents a clas-
sical negative feedback loop required to regulate the
magnitude and duration of signalling downstream of the
IFNG receptor signalling, in addition to limiting the
response to any subsequent cytokine stimulus [29,30].
IER3 (immediate early response 3) a stress inducible gene
is a target gene of the NF-?B signalling complex NFKB1-
RELA [31] and is known to be activated in response to a
variety of cellular stress signals [32-35]. Although IER3 is
not depicted to be directly induced by Jak-Stat signalling
we understand that connectivity exists between this sig-
nalling system and the NF-?B pathway. 25 components of
the pathway diagram were also regulated 2–4 hours post-
Ifng treatment (Figure 7b). Most noticeably members of
apoptosis and TLR signalling were changing during this
time and interestingly these changes occurred around the
initiation or receptor signalling region of these pathways.Page 9 of 15
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Follow through of signalling pathways stimulated by IFNG (6a) and FASLG (6b)igure 6
Follow through of signalling pathways stimulated by IFNG (6a) and FASLG (6b). The signalling events following the 
input signals of IFNG and FASLG have been highlighted on the entire map in lilac and orange, respectively. The nodes activated 
or directly affected by FASLG or IFN-gamma binding to their receptors are coloured and the interaction edges and gates are 
also highlighted. Nodes and edges not directly downstream of the FASLG or IFNG signalling are shown in grey. This figure 
demonstrates inputs into the pathway can clearly be followed to the expected outcome events. In the case of IFNG-input, gene 
transcription is the resulting event, and in the case of FASLG, apoptosis. Furthermore these examples clearly depict the inter-
actions of the pathway can be followed logically and do not result in unexpected crosstalk.
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potential mechanisms of apoptosis induction were tar-
geted; TNF, TNFRSF10 and FAS signalling. TNF, its recep-
tor TNFRSF1A and an adaptor protein RIPK1 are all up-
regulated, as is TNFSF10 (Trail-ligand). FAS and adaptor
molecules (DAXX and CFLAR) of the FAS receptor were
also increased in their expression. A similar observation
was also made for TLR-signalling, as a number of key
adaptors proteins (including MYD88 and IRAK2) were
up-regulated in the 2–4 hour timeframe. By activating the
TLR system and apoptotic machinery the cells appear to
preparing themselves for contact with pathogens and
priming themselves for apoptosis. One possible conse-
quence of TLR signalling when followed though on the
pathway diagram is the activation of the IRF5 transcrip-
tion factor and indeed 5 targets of IRF5 were up-regulated
at the 2–4 hour time phase (CXCL11, IFIT1, CXCL10,
IFIT2, and TNFSF10). Moreover IRF5 was itself regulated
at the later time points (4–8 hours) post-IFNG treatment.
Another consequence of TLR-signalling is the activation of
the NF-?B pathway and again the key constituents of this
pathway (NFKB1 and RELA) were activated at the later
time points as were some transcriptional targets of this
complex. During the 4–8 hours period BID, an important
amplifier of apoptotic input signals via the mitochondrial
apoptotic pathway, was up-regulated (Figure 7c). BID can
be cleaved and activated by any of the three aforemen-
tioned apoptotic mechanisms (FASLG, TNFSF10 and
TNF) [36-38] that were altered during the earlier time
phase. Also up during the latter hours were members of
the Jak-Stat pathway (JAK2, STAT1, STAT2, and PRKCD
which phosphorylates and activates STAT1) and some tar-
get genes of the Jak-Stat pathway, which could represent
increased sensitivity to IFN or other cytokine signalling.
The integrated pathway diagram presented at (a) 1–2 hours, (b) 2–4 hours and (c) 4–8 hours post-Ifng treatmentFigure 7
The integrated pathway diagram presented at (a) 1–2 hours, (b) 2–4 hours and (c) 4–8 hours post-Ifng treat-
ment. Differentially expressed genes are highlighted in red and the possible consequential downstream events resulting from 
the changes, (assuming de novo protein synthesis) are highlighted in blue.
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covers only a relatively small number of the genes shown
to be transcriptionally regulated following Ifng treatment.
For instance none of the genes shown to be down-regu-
lated by Ifng are shown in the diagram. However even
with the current limited coverage we have been able to
extrapolate some interesting observations by visualizing
the changes and the possible downstream effect of the
changes. It has been possible to appreciate the connectiv-
ity and co-dependency of the changes over time and using
this approach the detail of how signalling in one region
may have downstream effects on another signalling sys-
tem can be hypothesized and in many examples here
extracted.
Critical Review of Pathway
In constructing this integrated map of macrophage activa-
tion pathways we have attempted to represent events in a
detailed, accurate and logical fashion. However, it must be
emphasized that this map is by its nature a biased view of
events. Its construction has been primarily driven by our
interest in understanding signalling events in the macro-
phage and interpretation of the literature is an unavoida-
bly flawed process; determining what constitutes good
evidence for an interaction and what does not, is often dif-
ficult to judge especially for those who do not specifically
work in the area. Furthermore, any view of what consti-
tutes a given pathway is also highly subjective and is
always being driven by an individual's perspective and sci-
entific trends, as well as current knowledge. Even though
pathway diagrams typically depict individual pathways in
isolation of other systems, in reality it is well recognized
that there is significant overlap in pathway membership
and cross-talk between related pathways. Input from one
signalling pathway can influence the outcome in another,
underscoring the need to view the connections between
various signalling systems. Indeed, when one searches for
the known interactions of any well characterized protein
using database tools such as String [39] or Ingenuity [40]
one is potentially led in many directions, each interacting
protein in turn leading to an ever expanding network of
molecular interactions. Therefore when drawing pathway
maps such as the one described here, it is impossible to
include all the known interactions of any given compo-
nent. We are aware there are other systems important in
their regulation which have could be included, most
noticeably, NOD/NALP receptor signalling, MAP kinase
cascades, interleukin and other cytokine/chemokine sys-
tems, many aspects of the TNF-family of proteins, antigen
presentation and cell cycle pathway, to name but a few.
Some of these systems are now being added to the path-
way diagram but this is largely being driven by our need
to interpret the results of systems-level analysis of the
macrophages response to pathogens and cytokines.
Indeed, the fact that this pathway is far from complete is
further emphasized by its use in interpreting the transcrip-
tional response to Ifng. Of the 1,141 transcripts falling
into clusters of co-regulated genes following Ifng treat-
ment, only 55 were represented on the map and the map
so far includes only 44 genes in total as being regulated by
any transcription factor. This therefore highlights the fact
that there is some considerable way to go if we are to gen-
erate a complete model of the potential downstream
events following the interferon signalling cascade.
In the case of the signalling systems described here, the
interaction data is derived from the available literature
and is therefore dependant on the quality of that work,
the biological system from which that information was
derived and as already mentioned represents a subjective
view of the information available. Seldom do signalling
pathways operate independently of each other therefore
analyzing only a subset of nodes known to belong to a
particular pathway is unlikely to be insightful as to the
activity of the system as a whole. With so many of pieces
of the jigsaw missing and many aspects of the activity of
these large integrated molecular networks still unknown,
performing meaningful analyses on relatively small sec-
tions of what is otherwise an immense network of inter-
acting proteins, is unlikely to deliver accurate or
biologically representative predictions for some time.
The current notation system used for the pathway pre-
sented here arguably works well up to this size of pathway
and the end result we hope will serve as a useful reference
for biologists interested in these systems. However, scala-
bility of pathway diagrams is an important issue especially
when a compromise must be reached between presenting
a human readable map with one that captures the exten-
sive interaction data now available for many molecules.
Although we intend to continue to consolidate and add
interactions to the current map we are aware that this
could prove difficult in number of respects. When new
components are added, in order to place them near to the
site of their interacting partners the layout of the entire
graph sometimes needs to be manually altered to make
space. Furthermore, as functional units of an integrated
pathway network frequently share components, proteins
often referred to as hubs, it is often impossible to place a
component near to all its interacting partners requiring
edges (interactions) to span large distances across the
map. One method of reducing long edge lengths is to
depict individual components more than once within a
given cellular compartment. However, this in turn adds to
the issue of scalability as the additional nodes consume
more space, add more complexity and the visual link
between components of the pathway are lost. We have
therefore been exploring alternative approaches to over-
come the issue of scalability in pathway depictions. One
approach is to use automated layout algorithms to drawPage 12 of 15
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layout algorithms are very effective at displaying connec-
tivity between components with little or no need for man-
ual intervention (Figure 4a & b). This allows the rendering
of relatively large pathway diagrams quickly and easily,
whilst retaining much of the biologist friendly aspects to
the diagrams. What is lost is the spatial layout according
to the cellular compartment of components. However this
aspect can be retained, at least in part, by the use of colour
to signify in which compartment they reside. A second
approach for dealing with large interaction networks/
pathways is to visualize them in 3-dimensional space.
Using the tool BioLayout Express3D recently developed by
us [23] we have found it possible to render very large net-
works. In this instance the shape, size and colour can all
be used to distinguish between different component types
and colour can be overlaid to indicate cellular compart-
ment (Figure 4d). Whilst arrow heads are not supported in
3-D mode directionality is reinstated when graphs or
selected portions of large graphs are converted to 2-D net-
works.
Conclusion
With the majority of the components of life defined, at
least at some level, there is an increasing desire to put the
parts together in order to construct models of biological
systems which can be tested and refined. In this respect,
the value of logically presented pathway diagrams is
becoming ever more apparent given the growing need to
systematically organize and describe the interactions
between the various components that make up a cell.
Pathway diagrams serve several purposes; they can be
used to capture a large amount of information, provide a
point of reference for researchers with an interest in the
pathway or particular member of that pathway, and can
be used to aid the interpretation of systems level analyses.
The pathway presented here is by no means a comprehen-
sive view of all the pathways involved in macrophage acti-
vation, but acts a worked example of how a number of key
pathways might be represented in what we hope is a logi-
cal and unambiguous fashion. However, with the visual
modifications to the EPN scheme we believe we have ful-
filled the primary objectives of providing a graphical nota-
tion that is both useable by biologists and which could
still serve as the basis for computational model develop-
ment. So whilst others have gone some way to address the
issue of human readability of their pathway diagrams we
believe that we have derived an elegant yet simple nota-
tion scheme that better addresses the needs of biologists.
The mapping process is a continuing effort and during the
next steps we aim to consolidate and expand the content
of the diagram. This in turn may require refinements to
the notation system as issues in depicting the relation
between components and the cellular components in
which they are active arise. As we enhance our under-
standing of individual signalling pathways and how they
integrate with others this will aid understanding of immu-
nological disorders at a molecular level. Building pathway
diagrams or networks of interactions from the existing
knowledgebase is one of the milestones towards the appli-
cation of pathway and systems biology to the field of
medicine.
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